StockData
VCRENasdaqPharmaceutical PreparationsFiscal year ends December 31

Vicore Pharma Holding AB

$8.85−0.13 (-1.45%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Vicore Pharma Holding AB has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Vicore Pharma Holding AB filed with the SEC